Bioimpacts. 2025;15: 26443 | Published on: 2024 Apr 22. doi: 10.34172/bi.2023.26443

Original Article

Mosaic vaccine design targeting mutational spike protein of SARS- CoV-2: An immunoinformatics approach

Ysrafil Ysrafil ¹ , Arlan K. Imran ², Prisca Syafriani Wicita ², Vyani Kamba ², Fihrina Mohamad ², Ismail Ismail ³, Ayyub Harly Nurung ⁴, Noviyanty Indjar Gama ⁵, Sari Eka Pratiwi ⁶, Indwiani Astuti ⁷ , Firzan Nainu ⁸, Talha Bin Emran ⁹

Cited by CrossRef: 2

1- Nugraha M, Changestu D, Ramadhan R, Salsabila T, Nurizati A, Pratiwi S, Ysrafil Y. Novel prophylactic and therapeutic multi-epitope vaccine based on Ag85A, Ag85B, ESAT-6, and CFP-10 of Mycobacterium tuberculosis using an immunoinformatics approach. PHRP. 2024;15(4):286 [Crossref]

2- Ryan N, Pratiwi S, Mardhia M, Ysrafil Y, Liana D, Mahyarudin M. Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer. PHRP. 2024;15(4):307 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons